Nicholas Chiorazzi (N Chiorazzi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 13

Top Venues

Nature communications

Leukemia

Blood

Proceedings of the National Academy of Sciences of the United States of America

Feinstein Institute for Medical Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Feinstein Institute for Medical Research Feb 05 2000

United States

Professor and Center Head :: Oncology Research

Publications

Florian Märkl, Christoph Schultheiß, Murtaza Ali, Shih-Shih Chen, Marina Zintchenko, Lukas Egli, Juliane Mietz, Obinna Chijioke, Lisa Paschold, Sebastijan Spajic, Anne Holtermann, Janina Dörr, Sophia Stock, Andreas Zingg, Heinz Laubli, Ignazio Piseddu, David Anz, Marcus Dühren-von Minden, Tianjiao Zhang, Thomas Nerreter, Michael Hudecek, Susana Minguet, Nicholas Chiorazzi, Sebastian Kobold, Mascha Binder
Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia. Nature communications 15 (1) (2024)
Florian Märkl, Christoph Schultheiß, Murtaza Ali, Shih-Shih Chen, Marina Zintchenko, Lukas Egli, Juliane Mietz, Obinna Chijioke, Lisa Paschold, Sebastijan Spajic, Anne Holtermann, Janina Dörr, Sophia Stock, Andreas Zingg, Heinz Laubli, Ignazio Piseddu, David Anz, Marcus Dühren-von Minden, Tianjiao Zhang, Thomas Nerreter, Michael Hudecek, Susana Minguet, Nicholas Chiorazzi, Sebastian Kobold, Mascha Binder
Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia. Nature communications 15 (1) (2024)
Florian Märkl, Christoph Schultheiß, Murtaza Ali, Shih-Shih Chen, Marina Zintchenko, Lukas Egli, Juliane Mietz, Obinna Chijioke, Lisa Paschold, Sebastijan Spajic, Anne Holtermann, Janina Dörr, Sophia Stock, Andreas Zingg, Heinz Laubli, Ignazio Piseddu, David Anz, Marcus Dühren-von Minden, Tianjiao Zhang, Thomas Nerreter, Michael Hudecek, Susana Minguet, Nicholas Chiorazzi, Sebastian Kobold, Mascha Binder
Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia. Nature communications 15 (1) (2024)
Florian Märkl, Christoph Schultheiß, Murtaza Ali, Shih-Shih Chen, Marina Zintchenko, Lukas Egli, Juliane Mietz, Obinna Chijioke, Lisa Paschold, Sebastijan Spajic, Anne Holtermann, Janina Dörr, Sophia Stock, Andreas Zingg, Heinz Laubli, Ignazio Piseddu, David Anz, Marcus Dühren-von Minden, Tianjiao Zhang, Thomas Nerreter, Michael Hudecek, Susana Minguet, Nicholas Chiorazzi, Sebastian Kobold, Mascha Binder
Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia. Nature communications 15 (1) (2024)
Anita Ng, Francesca Lovat, Andrew J Shih, Yuhong Ma, Yuri Pekarsky, Frank DiCaro, Lita Crichton, Esha Sharma, Xiao Jie Yan, Daqian Sun, Tengfei Song, Yong-Rui Zou, Britta Will, Carlo M Croce, Nicholas Chiorazzi
Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state. Proceedings of the National Academy of Sciences of the United States of America 120 (43) (2023)
Andrea N Mazzarello, Mark Fitch, Martina Cardillo, Anita Ng, Sabreen Bhuiya, Esha Sharma, Davide Bagnara, Jonathan E Kolitz, Jacqueline C Barrientos, Steven L Allen, Kanti R Rai, Joanna Rhodes, Marc K Hellerstein, Nicholas Chiorazzi
Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli. Cancers 15 (19) (2023)
Shih-Shih Chen, Jacqueline Claudia Barrientos, Gerardo Ferrer, Morgan King-Richards, Yu-Ju Chen, Priyadarshini Ravichandran, Michael Ibrahim, Yasmine Kieso, Sheila Waters, Jeffery L Kutok, Marisa Peluso, Sujata Sharma, David T Weaver, Jonathan A Pachter, Kanti R Rai, Nicholas Chiorazzi
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Pablo Elías Morande, Xiao-Jie Yan, Julieta Haydee Sepúlveda Yáñez, Noé Seija, María Elena Marquez, Natalia Sotelo, Cecilia Abreu, Martina Crispo, Gabriel Fernández-Graña, Natalia Rego, Therence Bois, Stephen P Methot, Florencia Palacios, Victoria Remedi, Kanti R Rai, Alejandro Buschiazzo, Javier M Di Noia, Marcelo A Navarrete, Nicholas Chiorazzi, Pablo Oppezzo
AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms. Blood 138 (3) (2021)
Gerardo Ferrer, Byeongho Jung, Pui Yan Chiu, Rukhsana Aslam, Florencia Palacios, Andrea Nicola Mazzarello, Stefano Vergani, Davide Bagnara, Shih-Shih Chen, Sophia Yancopoulos, Aliki Xochelli, Xiao-Jie Yan, Jan A Burger, Jacqueline C Barrientos, Jonathan E Kolitz, Steven L Allen, Kostas Stamatopoulos, Kanti R Rai, Barbara Sherry, Nicholas Chiorazzi
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL. Leukemia 35 (11) (2021)
Florencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, Shih-Shih Chen, Stefano Vergani, Xuejing Yang, Jeffrey Gardner, Jaqueline C Barrientos, Philip Rock, W Richard Burack, Jonathan E Kolitz, Steven L Allen, Michael Gregory Kharas, Omar Abdel-Wahab, Kanti R Rai, Nicholas Chiorazzi
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target. Leukemia 35 (4) (2021)
Rashmi Gupta, Wentian Li, Xiao-Jie Yan, Jacqueline Barrientos, Jonathan E Kolitz, Steven L Allen, Kanti R Rai, Nicholas Chiorazzi, Patricia K A Mongini
Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins. Journal of immunology (Baltimore, Md. : 1950) 202 (10) (2019)
Benchang Guo, Lu Zhang, Nicholas Chiorazzi, Thomas L Rothstein
IL-4 rescues surface IgM expression in chronic lymphocytic leukemia. Blood 128 (4) (2016)
E Young, D Noerenberg, L Mansouri, V Ljungström, M Frick, L-A Sutton, S J Blakemore, J Galan-Sousa, K Plevova, P Baliakas, D Rossi, R Clifford, D Roos-Weil, V Navrkalova, B Dörken, C A Schmitt, K E Smedby, G Juliusson, B Giacopelli, J S Blachly, C Belessi, P Panagiotidis, Nicholas Chiorazzi, F Davi, A W Langerak, D Oscier, A Schuh, G Gaidano, Paolo Ghia, W Xu, L Fan, O A Bernard, F Nguyen-Khac, L Rassenti, J Li, T J Kipps, K Stamatopoulos, S Pospisilova, T Zenz, C C Oakes, J C Strefford, R Rosenquist, F Damm
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. Leukemia 31 (7) (2016)

Nicholas Chiorazzi.css-eqlu8i{font-size:small;padding-left:4px;} (N Chiorazzi)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas Chiorazzi (N Chiorazzi)